Baby And Toddler BioNTech Jabs Arrive In Hong Kong
"); jQuery("#212 h3").html("

"); });
2022-11-05 HKT 00:18
The government on Friday said a batch of about 96,000 shots of the baby and toddler version of the BioNTech Covid vaccine had arrived in Hong Kong. Distributed here under the name Comirnaty, the vaccine is for children aged between six months and four years.
Last month, the government signed off on the use of the toddler version of the mRNA vaccine, after taking into account the views of experts on a government-appointed advisory panel.
Previously the BioNTech shot had only been given to those aged five and above, while the Sinovac inactivated virus jab was made available for younger children in August.
Government advisers had previously said that BioNTech was safe for infants, but that they would require a dose of around a tenth of that given to adults.
XTransfer Partners With Bank SinoPac HK To Expand Cross-Border Payment Services
XTransfer has entered into a collaboration with Bank SinoPac, through its Hong Kong Branch, to expand international ope... Read more
Standard Chartered To Launch Bitcoin And Ethereum Custody Services By 2026
Standard Chartered Bank (Hong Kong) participated in Hong Kong Fintech Week 2025 (HKFTW25) as a strategic partner, annou... Read more
HashKey And Kraken Form Partnership On Institutional Tokenised Assets
HashKey and Kraken have announced a strategic partnership to promote institutional adoption of tokenised assets. The co... Read more
Reap Expands Global HQ With New Office In Hong Kong
Reap, a global fintech company providing stablecoin-enabled financial infrastructure, has expanded its global headquart... Read more
HeyMax Debuts In Hong Kong, Partnering With Cathay To Drive Regional Growth
Loyalty and travel rewards platform HeyMax has made its first international launch in Hong Kong, partnering with Cath... Read more
